Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yuejiao Zou"'
Autor:
Kevin J. Haworth, George L Britton, Shaoling Huang, Eva Golunski, Yuejiao Zou, David D. McPherson, Tao Peng, Melvin E. Klegerman, Ali Naji, Christy K. Holland
Publikováno v:
Journal of Liposome Research. 26:47-56
Bevacizumab (BEV) is a monoclonal antibody to vascular endothelial growth factor (VEGF) that ameliorates atheroma progression by inhibiting neovascularization.We aimed to determine whether BEV release from echogenic liposomes (BEV-ELIP) could be enha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e497fbfe7c229067677a01e1272ed1a
https://doi.org/10.3109/08982104.2015.1029494
https://doi.org/10.3109/08982104.2015.1029494
Publikováno v:
Journal of liposome research. 24(3)
Thermodynamic analysis of ligand-target binding has been a useful tool for dissecting the nature of the binding mechanism and, therefore, potentially can provide valuable information regarding the utility of targeted formulations. Based on a consiste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c8c65ef679effada57f5b3e735b6d9
https://pubmed.ncbi.nlm.nih.gov/24597467
https://pubmed.ncbi.nlm.nih.gov/24597467
Autor:
Melvin E Klegerman, Yuejiao Zou, George L Britton, Ali K Naji, Shao-Ling Huang, David D McPherson
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 32
Introduction. Bevacizumab (BEV) is a humanized monoclonal antibody to vascular endothelial growth factor (VEGF) that can ameliorate atheroma progression, the mechanism of which is believed to be through inhibition of neovascularization. Systemically,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::740227a48bc8b3366a3a4346fc0490bc
https://doi.org/10.1161/atvb.32.suppl_1.a342
https://doi.org/10.1161/atvb.32.suppl_1.a342
Autor:
Chen Min Yang, Duane C. Kraemer, Christy K. Holland, Yuejiao Zou, Xinyi Ge, Yong-Jian Geng, Hyunggun Kim, Stephanie M. Herbst, Shaoling Huang, Michael Wassler, David D. McPherson, Jonathan A. Kopechek, Jiangbo Qi, Melvin E. Klegerman, Harnath Shelat, Melanie R. Moody, Fred J. Clubb
Publikováno v:
Molecular pharmaceutics. 7(1)
In atherosclerosis, the loss of vascular stem cells via apoptosis impairs the capacity of the vascular wall to repair or regenerate the tissue damaged by atherogenic factors. Recruitment of exogenous stem cells to the plaque tissue may repopulate vas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e583b1d50a1a378903131b0da44349
https://pubmed.ncbi.nlm.nih.gov/19719324
https://pubmed.ncbi.nlm.nih.gov/19719324
Autor:
Melvin E. Klegerman, Michael Wassler, Hyunggun Kim, Christy K. Holland, Yong-Jian Geng, Yuejiao Zou, Harnath Shelat, Shaoling Huang, David D. McPherson
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 142(3)
Intrinsically echogenic liposomes (ELIP) can be adapted to encapsulate nitric oxide to facilitate ultrasound-enhanced delivery of therapeutic agents to atherosclerotic plaques. However, the NO loading of targeted ELIP caused a 93% decrease of antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5dc75de898d1ac74ffcdc12022b7939
https://pubmed.ncbi.nlm.nih.gov/19903503
https://pubmed.ncbi.nlm.nih.gov/19903503
Publikováno v:
Journal of liposome research. 18(2)
Fibrin-specific molecular targeting strategies are desirable for site-specific imaging and treatment of late stage atheroma, but fibrin-specific antibodies are difficult to produce and present immunogenicity problems. Tissue plasminogen activator (tP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6149622ac1874fda0cc26c0dd33538e
https://pubmed.ncbi.nlm.nih.gov/18569446
https://pubmed.ncbi.nlm.nih.gov/18569446
Autor:
Melanie Moody, Susan T Laing, Shaoling Huang, Hyunggun Kim, Beverly Smulevitz, Yuejiao Zou, David D McPherson, Melvin E Klegerman
Publikováno v:
Circulation. 116
Background: Ultrasound has been shown to enhance thrombolysis when used in conjunction with a thrombolytic agent. We have loaded echogenic liposomes (ELIP) with tissue plasminogen activator (tPA) and shown that mechanical non-imaging 1 MHz ultrasound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e1f3134a8e2deafcfeaaf3b687cd684
https://doi.org/10.1161/circ.116.suppl_16.ii_646-d
https://doi.org/10.1161/circ.116.suppl_16.ii_646-d
Publikováno v:
Chembiochem : a European journal of chemical biology. 8(17)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26c9b16be02ecb842251a35af59d71c
https://pubmed.ncbi.nlm.nih.gov/17924602
https://pubmed.ncbi.nlm.nih.gov/17924602